Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives $20.20 Average Target Price from Brokerages
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the […]
20 Mar 10:00 · The Markets Daily